News
Hims & Hers Rallies After Novo Nordisk Deal on Wegovy
In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week, the company said. Shares of Hims & Hers soared 30% to $36.94 premarket, but remain below February peaks. Novo Nordisk rose 4% to $65.10.
A PRESENTER has candidly opened up on her “absolutely horrendous” experience while using Mounjaro. Danielle Mason, an ...
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
Health and wellness influencer Janelle Rohner has received backlash after revealing in a YouTube video posted on April 23 ...
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
Curbs will have to be put on which patients are to be eligible for weight loss jabs Mounjaro and Wegovy when they are added ...
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...
5d
Fans of Meghan Trainor have been in awe of her weight loss transformation in 2025 and have been wondering how she achieved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback